About Us

arrow-icon
Back to About Us
member-photo-1

Donna Harrison, M.D.

Associate Scholar

Donna Harrison, M.D.is a board-certified obstetrician and gynecologist and Executive Director of the American Association of Prolife Obstetricians and Gynecologists (www.aaplog.org).  AAPLOG is the largest pro-life physician organization in the world, and was recognized as a special interest group within the American College (Congress) of Obstetrics and Gynecology (ACOG) for over 40 years from 1973 to 2013, until ACOG discontinued the use of the term “special interest group” within the Congress.

Dr. Harrison’s research interests include selective progesterone receptor modulators, endometrial contraception, maternal mortality, abortion long term morbidity, and medical abortion.

She has lectured extensively as a continuing medical education speaker in the United States and internationally on topics of medical abortion with mifepristone and misoprostol, adverse events associated with mifepristone and misoprostol, emergency contraception with ulipristal, maternal mortality and the association with abortion, and post abortion short- and long-term complications.  She is an adjunct professor at Trinity International University in Deerfield, IL, recently teaching a postgraduate continuing medical education seminar on current reproductive technologies ethical implications.  She has authored peer-reviewed papers on the RU-486 approval process, adverse events associated with medical abortion with mifepristone and misoprostol, and mechanisms of action of ulipristal.

She has also spoken before the FDA Reproductive Health Advisory Committees on mifepristone and ulipristal and has addressed numerous congressional committees, as well as presenting at the United Nations Committee on the Status of Women accessory sessions on topics related to medical abortion in developing nations, and maternal mortality and abortion.

Latest Research & News

  • Abortion Increases Risk of Preterm Birth: More Evidence in New Publication | May 13, 2016

    The recent systematic review published by Gabrielle Saccone and colleagues joins the long list of over 150 studies over the past four decades which extensively document that having an induced abortion increases a woman’s risk of preterm birth in subsequent pregnancies. Saccone et al. clearly document again what other authors have repeatedly published; a fact also acknowledged by the Institute of Medicine (IOM) in their report on preterm birth in 2005. However, unlike the IOM, who hid the association on page 625 in Appendix B, Saccone places the facts in the open: “Prior surgical uterine evacuation for either I-TOP [induced termination of pregnancy] or SAB [spontaneous abortion] is an independent risk factor for PTB [preterm birth].” Translated, that means any time the womb of a pregnant woman is forced open, there is a risk of damaging the opening of the womb.

  • Good News for Pregnant Moms Diagnosed with Cancer, and Good News for their Unborn Babies | October 20, 2015

    Separation of a mother and her unborn child is tragically sometimes necessary to save the life of the mother. But the number of conditions which truly threaten the mother’s life, and which require a life-saving separation of the mother and her baby are vanishingly small. A new study by Amant and colleagues, entitled “Pediatric Outcome after Maternal Cancer Diagnosed during Pregnancy,” brings tremendous hope to pregnant women who have courageously carried their unborn children to birth, despite the need for chemotherapy or radiation therapy. And the successful outcome of these children exposed in utero to radiation, chemotherapy or a combination of both is reassuring to pregnant women who no longer need be told outdated information that they must abort their children or else risk compromising their own care or their child’s life.